The Regulatory Role of IL-10 in Neurodegenerative Diseases.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
09 07 2020
Historique:
received: 29 05 2020
revised: 01 07 2020
accepted: 07 07 2020
entrez: 15 7 2020
pubmed: 15 7 2020
medline: 17 4 2021
Statut: epublish

Résumé

IL-10, an immunosuppressive cytokine, is considered an important anti-inflammatory modulator of glial activation, preventing inflammation-mediated neuronal degeneration under pathological conditions. In this narrative review, we summarize recent insights about the role of IL-10 in the neurodegeneration associated with neuroinflammation, in diseases such as Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic lateral sclerosis, Alzheimer's Disease, and Parkinson's Disease, focusing on the contribution of this cytokine not only in terms of protective action, but also as possibly responsible for clinical worsening. The knowledge of this double face of the same coin, regarding the biological role of the IL-10, could aid the development of targeted therapies useful for limiting neurodegenerative processes.

Identifiants

pubmed: 32659950
pii: biom10071017
doi: 10.3390/biom10071017
pmc: PMC7407888
pii:
doi:

Substances chimiques

IL10 protein, human 0
Interleukin-10 130068-27-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Cytokine Growth Factor Rev. 2017 Apr;34:1-13
pubmed: 28365229
Front Neurol. 2013 Mar 04;4:18
pubmed: 23459929
Neurol Sci. 2019 Jan;40(1):113-120
pubmed: 30315378
Pharmacol Rep. 2014 Aug;66(4):660-9
pubmed: 24948069
Eur J Med Res. 2008 Oct 27;13(10):464-8
pubmed: 19008173
Neurobiol Aging. 2007 Jun;28(6):894-906
pubmed: 21887889
PLoS One. 2018 Feb 21;13(2):e0193278
pubmed: 29466474
J Autoimmun. 2018 Mar;88:103-113
pubmed: 29146546
Neuron. 2015 Feb 4;85(3):534-48
pubmed: 25619654
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11267-71
pubmed: 8248239
Trends Immunol. 2015 Oct;36(10):605-613
pubmed: 26431938
J Exp Med. 1989 Dec 1;170(6):2081-95
pubmed: 2531194
Meta Gene. 2016 Jan 11;8:1-10
pubmed: 27014584
Immunol Rev. 2008 Dec;226:205-18
pubmed: 19161426
Brain Behav Immun. 2009 Aug;23(6):794-802
pubmed: 19272439
Neuromodulation. 2012 Nov-Dec;15(6):520-6; discussion 526
pubmed: 22672183
Front Neurol. 2017 Jun 12;8:244
pubmed: 28659854
Biomed Res Int. 2018 Aug 16;2018:6091014
pubmed: 30186862
J Geriatr Psychiatry Neurol. 2009 Mar;22(1):23-34
pubmed: 19196630
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1968-1972
pubmed: 30078676
Int Immunopharmacol. 2017 Sep;50:353-360
pubmed: 28753520
Nat Med. 2000 Apr;6(4):422-8
pubmed: 10742149
Neurosci Lett. 2018 Sep 14;683:181-184
pubmed: 30063943
Sci Rep. 2020 Apr 3;10(1):5941
pubmed: 32246039
Arq Bras Cardiol. 2009 Dec;93(6):643-51, 692-700
pubmed: 20379646
Brain Behav Immun. 2013 Mar;29:70-81
pubmed: 23261777
Immunity. 2009 Aug 21;31(2):209-19
pubmed: 19646904
Front Immunol. 2018 Mar 19;9:455
pubmed: 29616018
Glia. 2006 Apr 15;53(6):583-92
pubmed: 16419089
J Immunol Res. 2017;2017:6257958
pubmed: 28321419
J Neuroinflammation. 2016 May 24;13(1):121
pubmed: 27220674
Can J Neurol Sci. 2012 Jan;39(1):58-64
pubmed: 22384497
J Neuroimmunol. 2002 Oct;131(1-2):168-72
pubmed: 12458048
J Exp Med. 1998 Feb 16;187(4):571-8
pubmed: 9463407
Pharmacol Rep. 2013;65(1):44-9
pubmed: 23563022
N Engl J Med. 2008 Feb 14;358(7):676-88
pubmed: 18272891
Immunology. 2014 Mar;141(3):302-13
pubmed: 23981039
J Steroid Biochem Mol Biol. 2014 Jul;142:99-106
pubmed: 23727128
J Neuroinflammation. 2013 Sep 22;10:117
pubmed: 24053338
Psychosomatics. 2010 Nov-Dec;51(6):474-9
pubmed: 21051678
Cell. 1998 May 1;93(3):373-83
pubmed: 9590172
Neurosci Bull. 2016 Oct;32(5):469-80
pubmed: 27568024
Curr Pharm Des. 2012;18(2):200-8
pubmed: 22229581
J Immunol. 2008 Apr 1;180(7):4763-73
pubmed: 18354200
Neurosci Lett. 2012 Apr 4;513(2):183-6
pubmed: 22387064
Biomed Pharmacother. 2018 Oct;106:349-354
pubmed: 29966980
J Neurol Sci. 2002 Oct 15;202(1-2):93-7
pubmed: 12220699
Brain Behav Immun. 2020 Jul;87:679-688
pubmed: 32135194
Neuron. 2015 Feb 4;85(3):519-33
pubmed: 25619653
Neuroimmunomodulation. 2012;19(6):377-85
pubmed: 23075771
Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5206-11
pubmed: 14638718
J Immunol. 2010 Mar 1;184(5):2638-45
pubmed: 20124100
Nat Commun. 2016 Jul 11;7:12134
pubmed: 27396388
Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):1-14
pubmed: 25998063
J Allergy Clin Immunol. 2007 May;119(5):1241-50
pubmed: 17353041
J Neuroinflammation. 2016 Oct 13;13(1):271
pubmed: 27737696
J Virol. 2018 Feb 26;92(6):
pubmed: 29263262
Brain Behav Immun. 2014 Feb;36:118-27
pubmed: 24513872
EMBO J. 1997 Oct 1;16(19):5894-903
pubmed: 9312047
Mod Pathol. 2011 Jun;24(6):801-9
pubmed: 21317876
J Immunol. 2004 Sep 15;173(6):3916-24
pubmed: 15356140
Nature. 2012 Nov 8;491(7423):264-8
pubmed: 23064231
Nat Med. 2005 Dec;11(12):1314-21
pubmed: 16288283
Gene Ther. 2012 Jul;19(7):724-33
pubmed: 21918553
J Cereb Blood Flow Metab. 2013 Dec;33(12):1955-66
pubmed: 24022622
Nat Med. 2002 Mar;8(3):240-6
pubmed: 11875494
Immunogenetics. 1997;46(2):120-8
pubmed: 9162098
J Immunol. 2002 Jun 15;168(12):6404-11
pubmed: 12055259
Int Immunopharmacol. 2015 Feb;24(2):369-376
pubmed: 25576658
Annu Rev Immunol. 2001;19:683-765
pubmed: 11244051
J Neurol Sci. 2017 May 15;376:242-254
pubmed: 28431620
J Clin Neurosci. 2018 Dec;58:30-33
pubmed: 30454693
Am J Reprod Immunol. 2015 Jun;73(6):487-500
pubmed: 25269386
J Biol Chem. 2007 Mar 9;282(10):6965-75
pubmed: 17194701
Behav Brain Res. 2017 Jan 1;316:189-196
pubmed: 27569183
J Neuroimmunol. 2002 Jan;122(1-2):9-19
pubmed: 11777539
Exp Mol Med. 2007 Dec 31;39(6):812-9
pubmed: 18160852
Neuropharmacology. 2015 Sep;96(Pt A):55-69
pubmed: 25446571
J Exp Med. 1991 Nov 1;174(5):1209-20
pubmed: 1940799
Cell. 2019 Oct 3;179(2):312-339
pubmed: 31564456
Cell Immunol. 2011;269(2):82-9
pubmed: 21571262
Cell Mol Life Sci. 2014 Oct;71(20):3969-85
pubmed: 25008043
Neurol Neuroimmunol Neuroinflamm. 2015 Aug 06;2(5):e138
pubmed: 26280014
Acta Neurol Scand. 2009 May;119(5):332-7
pubmed: 18976327
J Neurosci. 2016 Jan 20;36(3):1031-48
pubmed: 26791230
Front Cell Neurosci. 2012 Dec 12;6:58
pubmed: 23248582
J Neuroimmune Pharmacol. 2017 Jun;12(2):327-339
pubmed: 27987058
Menopause. 2016 Jul;23(7):803-5
pubmed: 27272226
Neurotherapeutics. 2010 Jan;7(1):22-30
pubmed: 20129494
J Neuroinflammation. 2019 Jan 5;16(1):2
pubmed: 30611291
Aging (Albany NY). 2019 Dec 4;11(23):10796-10813
pubmed: 31801113
Acta Neurol Scand. 2011 Sep;124(3):176-81
pubmed: 20880267
J Immunol. 2004 Jan 1;172(1):567-76
pubmed: 14688368
Cell Immunol. 2018 May;327:77-82
pubmed: 29478949
Science. 1990 Jun 8;248(4960):1230-4
pubmed: 2161559
Neuroimage Clin. 2017 Nov 21;17:587-595
pubmed: 29201645
Mov Disord. 2016 Jul;31(7):995-1003
pubmed: 26999434
JAMA Neurol. 2016 Nov 1;73(11):1316-1324
pubmed: 27668667
J Neuroimmunol. 2006 Sep;178(1-2):1-8
pubmed: 16872684
Neuron. 2015 Feb 4;85(3):450-2
pubmed: 25654250
Cell J. 2017 Oct;19(3):361-374
pubmed: 28836399
J Neuroinflammation. 2015 Jun 28;12:127
pubmed: 26126965
Immunol Rev. 2006 Aug;212:28-50
pubmed: 16903904

Auteurs

Chiara Porro (C)

Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.

Antonia Cianciulli (A)

Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.

Maria Antonietta Panaro (MA)

Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH